Alisa Lask - 01 Jan 2025 Form 4 Insider Report for NEPHROS INC (NEPH)

Role
Director
Signature
/s/ Christopher Melsha as attorney-in-fact for Alisa Lask pursuant to power of attorney previously filed.
Issuer symbol
NEPH
Transactions as of
01 Jan 2025
Transactions value $
$0
Form type
4
Filing time
03 Jan 2025, 17:08:03 UTC
Previous filing
16 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NEPH Common Stock 48,629 01 Jan 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEPH Stock Option (right to buy) Award $0 +7,050 $0.000000 7,050 01 Jan 2025 Common Stock 7,050 $1.47 Direct F4
holding NEPH Stock Option (right to buy) 9,617 01 Jan 2025 Common Stock 9,617 $5.22 Direct F1
holding NEPH Stock Option (right to buy) 5,568 01 Jan 2025 Common Stock 5,568 $8.57 Direct F1
holding NEPH Stock Option (right to buy) 6,850 01 Jan 2025 Common Stock 6,850 $8.06 Direct F1
holding NEPH Stock Option (right to buy) 7,062 01 Jan 2025 Common Stock 7,062 $6.82 Direct F1
holding NEPH Stock Option (right to buy) 7,080 01 Jan 2025 Common Stock 7,080 $1.07 Direct F2
holding NEPH Stock Option (right to buy) 7,323 01 Jan 2025 Common Stock 7,323 $2.14 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully exercisable.
F2 This option vests as to 2,360 shares on each of 1/5/23, 1/5/24 and 1/5/25.
F3 This option vests as to 2,441 shares on each of 5/14/24, 5/14/25 and 5/14/26.
F4 Represents options granted to the reporting person for her service on the Company's Board of Directors for 2024. This option vests as to 2,350 shares on each of 1/1/25, 1/1/26 and 1/1/27.